Last reviewed · How we verify
Guna-Rhino Nose (INTERLEUKIN-10)
At a glance
| Generic name | INTERLEUKIN-10 |
|---|---|
| Sponsor | Guna spa |
| Drug class | Standardized Insect Venom Allergenic Extract [EPC] |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- DETERMINATION OF THE EFFECTS OF STAINLESS STEEL CROWNS CEMENTED WITH RESIN CEMENTS ON INTERLEUKIN-10, 12, 18 LEVELS IN GINGIVAL CREVICULAR FLUID (NA)
- Investigation of the Relationship Between Periodontitis and Sleep Quality
- Interleukin 8 and10 Levels Changes in Teeth With Necrotic Pulp and Apical Periodontitis (NA)
- Pain, Central Sensitization and Psychoemotional State in Patients With Chronic Masticatory Muscle Pain
- Aerobic Exercise vs Physiological Ischemic Training in Stage 2 Hypertension (NA)
- Association of Periodontal Status and Smoking With Salivary Inflammasome Markers
- Effect of Dapagliflozin on Interleukin 10 in Sepsis
- Prevention of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Guna-Rhino Nose CI brief — competitive landscape report
- Guna-Rhino Nose updates RSS · CI watch RSS
- Guna spa portfolio CI